DISSOLUTION PROFILE STUDY OF EXTENDED RELEASE VALPROIC ACID DRUG PRODUCTS FROM DIFFERENT MANUFACTURERS

Dissolution profiles of four extended release valproic acid tablets from different manufacturers and granules Depakine® Chronosphere 500 mg were studied in three dissolution media: pH 1.2; 4.5, 6.8 (quality control medium). Dissolution profiles similarity for tablets was approved and more rapid diss...

Full description

Bibliographic Details
Main Authors:	D. Yu. Grebenkin, E. D. Ustinova, S. Yu. Gorbacheva, A. K. Faeva, V. I. Kazey, A. V. Ryabova
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	valproic acid dissolution profile testing hplc
Online Access:	https://www.pharmjournal.ru/jour/article/view/590

Similar Items

DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO)
by: A. A. Lvova, et al.
Published: (2019-01-01)

Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
by: D. Yu. Grebenkin, et al.
Published: (2023-02-01)

DISSOLUTION PROFILE STUDY FOR INNOVATION ANTI-RETROVIRAL DRUG PRODUCT NIKAVIR® AND ITS FIXED COMBINATION WITH LAMIVUDINE (PHOSPHALADINE®)
by: I. E. Shohin, et al.
Published: (2019-01-01)

<i>In-vitro</i> dissolution profiles comparison for various drugs with active ingredient Febuxostat commercially available on the Russian market
by: S. V. Denkina, et al.
Published: (2024-01-01)

MODERN APPROACHES OF DISSOLUTION PROFILE TEST (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

RETROSPECTIVE OF DISSOLUTION TEST OF SOLID DOSAGE FORMS (REVIEW)
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

Valproic Acid and Thrombocytopenia
by: J Gordon Millichap
Published: (1996-08-01)

Alternative Methods for Dissolution Profile Comparison in the Dissolution Test
by: D. P. Romodanovsky, et al.
Published: (2021-11-01)

Ammonia Blood Levels and Valproic Acid
by: J Gordon Millichap
Published: (2007-12-01)

Influence of immediate release tablet formulation on dissolution profile of paracetamol
by: Todorović Nemanja B., et al.
Published: (2018-01-01)

DISSOLUTION PROFILE STUDIES OF BCS CLASS II DRUG VALSARTAN BY BIOWAIVER PROCEDURE
by: E. R. Brigas, et al.
Published: (2019-01-01)

Chromatography-tandem MASS spectrometry (HPLC-MS/MS) for the detection of valproic acid and its metabolites in blood plasma
by: A. S. Malygin, et al.
Published: (2018-08-01)

Simvastatin assay and dissolution studies by feasible RP-HPLC in tablets
by: Flávia Dias Marques-Marinho, et al.
Published: (2012-01-01)

Pharmacokinetic Interactions of Phenosanic Acid with Valproic Acid and Carbamazepine in Dogs
by: M. V. Karlina, et al.
Published: (2022-12-01)

A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid
by: Ayesha Safdar, et al.
Published: (2023-02-01)

Hepatic Fatalities and Valproic Acid
by: J Gordon Millichap
Published: (1996-04-01)

Valproic Acid-induced Agranulocytosis
by: Hui-Chuan Hsu, et al.
Published: (2009-06-01)

Severe Valproic Acid Intoxication Responding to Hemodialysis
by: Ali Ertuğ Arslanköylü, et al.
Published: (2017-08-01)

Current Views on the Use of Valproic Acid in Women
by: Kezban ASLAN KARA, et al.
Published: (2019-08-01)

Chronic valproic acid intoxication in epileptology: diagnosis and treatment
by: N. A. Shnaider, et al.
Published: (2016-07-01)

An HPLC method for the determination of digoxin in dissolution samples
by: Milenković Miroslav Ž., et al.
Published: (2010-01-01)

Hallucinations after Valproic Acid Withdrawal
by: J Gordon Millichap
Published: (2012-08-01)

Chronotolerance study of the antiepileptic drug valproic acid in mice
by: Ben-Cherif Wafa, et al.
Published: (2012-05-01)

Choreiform Movements and Valproic Acid
by: J Gordon Millichap
Published: (1994-08-01)

Valproic Acid and Carnitine Metabolism
by: J Gordon Millichap
Published: (1991-11-01)

Valproic acid-induced hyperammonemic encephalopathy: a clinical case
by: M. Felizardo, et al.
Published: (2022-06-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF VALPROIC ACID DERIVATIVES
by: O. L. Badalyan, et al.
Published: (2016-05-01)

A validated high-performance liquid chromatography-ultraviolet method for the determination of valproic acid derivatives in pharmaceutical formulations with a microbiological suitability evaluation
by: Abdullah H. Alluhayb, et al.
Published: (2024-12-01)

Valproic acid-associated pancytopenia: A dose-dependent adverse effect
by: Jamir Pitton Rissardo, et al.
Published: (2019-09-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

A Critical Overview of FDA and EMA Statistical Methods to Compare In Vitro Drug Dissolution Profiles of Pharmaceutical Products
by: Jan Muselík, et al.
Published: (2021-10-01)

Thrombophilic Risk Factors with Valproic Acid
by: J Gordon Millichap
Published: (2009-02-01)

Valproic Acid-Induced Hair Curling
by: J Gordon Millichap
Published: (2007-03-01)

Acute pancreatitis induced by valproic acid
by: S. Khouadja, et al.
Published: (2021-04-01)

Frequency of Subclinic Hypothyroidism at the Patients That Are Using Valproic Acid
by: Mehmet Ibrahim Turan, et al.
Published: (2014-06-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR MOXIFLOXACINE TABLETS
by: L. A. Menshikova, et al.
Published: (2019-01-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS
by: A. A. Lvova, et al.
Published: (2019-01-01)

Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets
by: Gustavo Vaiano Carapeto, et al.
Published: (2023-05-01)

HIGH MOLECULAR CELLULOSE ESTERS. MECHANISM OF ACTION IN SUSTAINED RELEASE MATRIX TABLETS. DISSOLUTION PROFILE OF ACTIVE DRUG DEPENDING ON MOLECULAR WEIGHT AND HYDROPHILIC PROPERTIES OF POLYMERS
by: S. V. Trofimov
Published: (2015-11-01)

Valproic Acid and Sleep Duration in Children with Epilepsy
by: J Gordon Millichap
Published: (2009-09-01)